{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:28:24Z","timestamp":1791664104967,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging Mech Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adipocytes are not merely organs for energy conservation but endocrine organs secreting a wide array of physiologically active substances, i.e., adipokines. Of these adipokines, adiponectin is known to exert anti-diabetic and anti-atherosclerotic effects via adiponectin receptors (AdipoR)s, AdipoR1 and AdipoR2. Adiponectin has also recently been shown to regulate longevity signaling thus prolonging lifespan. Therefore, the strategy for activating adiponectin\/AdipoR signaling pathways are expected to provide a solid basis for the prevention and treatment of obesity-related diseases such as the metabolic syndrome, type 2 diabetes and cardiovascular disease, as well as for ensuring healthy longevity in humans.<\/jats:p>","DOI":"10.1038\/npjamd.2015.13","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T11:09:30Z","timestamp":1484737770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Adiponectin\/adiponectin receptor in disease and aging"],"prefix":"10.1038","volume":"1","author":[{"given":"Masato","family":"Iwabu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Okada-Iwabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"BFnpjamd201513_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng, M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766\u2013781 (2014).","journal-title":"Lancet"},{"key":"BFnpjamd201513_CR2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/35007504","volume":"404","author":"JM Friedman","year":"2000","unstructured":"Friedman, J. M. Obesity in the new millennium. Nature 404, 632\u2013634 (2000).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1099-0895(199703)13:1<3::AID-DMR178>3.0.CO;2-N","volume":"13","author":"Y Matsuzawa","year":"1997","unstructured":"Matsuzawa, Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes\/metabolism reviews 13, 3\u201313 (1997).","journal-title":"Diabetes\/metabolism reviews"},{"key":"BFnpjamd201513_CR4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","volume":"32","author":"G Reaven","year":"2012","unstructured":"Reaven, G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arteriosclerosis, thrombosis, and vascular biology 32, 1754\u20131759 (2012).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFnpjamd201513_CR5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625\u20131638 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnpjamd201513_CR6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(14)70085-7","volume":"13","author":"AJ Kiliaan","year":"2014","unstructured":"Kiliaan, A. J., Arnoldussen, I. A. & Gustafson, D. R. Adipokines: a link between obesity and dementia? The Lancet. Neurology 13, 913\u2013923 (2014).","journal-title":"The Lancet. Neurology"},{"key":"BFnpjamd201513_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/75610","volume":"25","author":"CR Kahn","year":"2000","unstructured":"Kahn, C. R. Triglycerides and toggling the tummy. Nature Genet. 25, 6\u20137 (2000).","journal-title":"Nature Genet."},{"key":"BFnpjamd201513_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425\u2013432 (1994).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","volume":"104","author":"BM Spiegelman","year":"2001","unstructured":"Spiegelman, B. M. & Flier, J. S. Obesity and the regulation of energy balance. Cell 104, 531\u2013543 (2001).","journal-title":"Cell"},{"key":"BFnpjamd201513_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87\u201391 (1993).","journal-title":"Science"},{"key":"BFnpjamd201513_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm0106-43","volume":"12","author":"MA Lazar","year":"2006","unstructured":"Lazar, M. A. The humoral side of insulin resistance. Nat. Med. 12, 43\u201344 (2006).","journal-title":"Nat. Med."},{"key":"BFnpjamd201513_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita, Y. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79\u201383 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnpjamd201513_CR13","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746\u201326749 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR14","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","volume":"271","author":"E Hu","year":"1996","unstructured":"Hu, E., Liang, P. & Spiegelman, B. M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697\u201310703 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","volume":"221","author":"K Maeda","year":"1996","unstructured":"Maeda, K. et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286\u2013296 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnpjamd201513_CR16","first-page":"802","volume":"120","author":"Y Nakano","year":"1996","unstructured":"Nakano, Y., Tobe, T., Choi-Miura, N. H., Mazda, T. & Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. (Tokyo) 120, 802\u2013812 (1996).","journal-title":"J. Biochem. (Tokyo)"},{"key":"BFnpjamd201513_CR17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0960-9822(98)70133-2","volume":"8","author":"L Shapiro","year":"1998","unstructured":"Shapiro, L. & Scherer, P. E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335\u2013338 (1998).","journal-title":"Curr. Biol."},{"key":"BFnpjamd201513_CR18","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","volume":"278","author":"UB Pajvan","year":"2003","unstructured":"Pajvan, U. B. et al. Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073\u20139085 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR19","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","volume":"278","author":"H Waki","year":"2003","unstructured":"Waki, H. et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278, 40352\u201340363 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR20","doi-asserted-by":"crossref","first-page":"50810","DOI":"10.1074\/jbc.M309469200","volume":"278","author":"TS Tsao","year":"2003","unstructured":"Tsao, T. S. et al. Role of disulfide bonds in Acrp30\/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J. Biol. Chem. 278, 50810\u201350817 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941\u2013946 (2001).","journal-title":"Nat. Med."},{"key":"BFnpjamd201513_CR22","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","volume":"98","author":"J Fruebis","year":"2001","unstructured":"Fruebis, J. et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA 98, 2005\u20132010 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjamd201513_CR23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","volume":"7","author":"AH Berg","year":"2001","unstructured":"Berg, A. H., Combs, T. P., Du, X., Brownlee, M. & Scherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947\u2013953 (2001).","journal-title":"Nat. Med."},{"key":"BFnpjamd201513_CR24","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI14120","volume":"108","author":"TP Combs","year":"2001","unstructured":"Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E. & Rossetti, L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108, 1875\u20131881 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnpjamd201513_CR25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","volume":"8","author":"N Maeda","year":"2002","unstructured":"Maeda, N. et al. Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat. Med. 8, 731\u2013737 (2002).","journal-title":"Nat. Med."},{"key":"BFnpjamd201513_CR26","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.C200251200","volume":"277","author":"N Kubota","year":"2002","unstructured":"Kubota, N. et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277, 25863\u201325866 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR27","doi-asserted-by":"crossref","first-page":"34658","DOI":"10.1074\/jbc.C200362200","volume":"277","author":"K Ma","year":"2002","unstructured":"Ma, K. et al. Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 277, 34658\u201334661 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR28","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","volume":"281","author":"AR Nawrocki","year":"2006","unstructured":"Nawrocki, A. R. et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281, 2654\u20132660 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR29","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1074\/jbc.M209033200","volume":"278","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi, T. et al. Globular adiponectin protected ob\/ob mice from diabetes and apoE deficient mice from atherosclerosis. J. Biol. Chem. 278, 2461\u20132468 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/en.2003-1068","volume":"145","author":"TP Combs","year":"2004","unstructured":"Combs, T. P. et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145, 367\u2013383 (2004).","journal-title":"Endocrinology"},{"key":"BFnpjamd201513_CR31","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/01.RES.0000119921.86460.37","volume":"94","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi, H. et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94, e27\u2013e31 (2004).","journal-title":"Circ. Res."},{"key":"BFnpjamd201513_CR32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2007.03.004","volume":"356","author":"Y Hada","year":"2007","unstructured":"Hada, Y. et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem. Biophys. Res. Commun. 356, 487\u2013493 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnpjamd201513_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki, T. & Yamauchi, T. Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439\u2013451 (2005).","journal-title":"Endocr. Rev."},{"key":"BFnpjamd201513_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jmb.2008.06.015","volume":"381","author":"M Radjainia","year":"2008","unstructured":"Radjainia, M., Wang, Y. & Mitra, A. K. Structural polymorphism of oligomeric adiponectin visualized by electron microscopy. J. Mol. Biol. 381, 419\u2013430 (2008).","journal-title":"J. Mol. Biol."},{"key":"BFnpjamd201513_CR35","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","volume":"50","author":"N Maeda","year":"2001","unstructured":"Maeda, N. et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094\u20132099 (2001).","journal-title":"Diabetes"},{"key":"BFnpjamd201513_CR36","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1248\/bpb.22.1158","volume":"22","author":"K Saito","year":"1999","unstructured":"Saito, K. et al. Regulation of gelatin-binding protein 28 (GBP28) gene expression by C\/EBP. Biol. Pharm. Bull. 22, 1158\u20131162 (1999).","journal-title":"Biol. Pharm. Bull."},{"key":"BFnpjamd201513_CR37","doi-asserted-by":"crossref","first-page":"22108","DOI":"10.1074\/jbc.M400238200","volume":"279","author":"JB Seo","year":"2004","unstructured":"Seo, J. B. et al. Adipocyte determination- and differentiation-dependent factor 1\/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J. Biol. Chem. 279, 22108\u201322117 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR38","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1128\/MCB.00931-06","volume":"27","author":"ZV Wang","year":"2007","unstructured":"Wang, Z. V. et al. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol. Cell. Biol. 27, 3716\u20133731 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"BFnpjamd201513_CR39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature05486","volume":"444","author":"L Guarente","year":"2006","unstructured":"Guarente, L. Sirtuins as potential targets for metabolic syndrome. Nature 444, 868\u2013874 (2006).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113\u2013118 (2005).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2008.08.014","volume":"8","author":"AS Banks","year":"2008","unstructured":"Banks, A. S. et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8, 333\u2013341 (2008).","journal-title":"Cell Metab."},{"key":"BFnpjamd201513_CR42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cell.2012.06.027","volume":"150","author":"L Qiang","year":"2012","unstructured":"Qiang, L. et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell 150, 620\u2013632 (2012).","journal-title":"Cell"},{"key":"BFnpjamd201513_CR43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","volume":"3","author":"M Bl\u00fcher","year":"2002","unstructured":"Bl\u00fcher, M. et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3, 25\u201338 (2002).","journal-title":"Dev. Cell"},{"key":"BFnpjamd201513_CR44","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","volume":"91","author":"RK Semple","year":"2006","unstructured":"Semple, R. K. et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J. Clin. Endocrinol. Metab. 91, 3219\u20133223 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnpjamd201513_CR45","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752\u20131761 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnpjamd201513_CR46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","volume":"302","author":"S Li","year":"2009","unstructured":"Li, S., Shin, H. J., Ding, E. L. & van Dam, R. M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179\u2013188 (2009).","journal-title":"JAMA"},{"key":"BFnpjamd201513_CR47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","volume":"360","author":"RS Lindsay","year":"2002","unstructured":"Lindsay, R. S. et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360, 57\u201358 (2002).","journal-title":"Lancet"},{"key":"BFnpjamd201513_CR48","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/jc.2006-1158","volume":"91","author":"R Nakashima","year":"2006","unstructured":"Nakashima, R. et al. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J. Clin. Endocrinol. Metab. 91, 3873\u20133877 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnpjamd201513_CR49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali, C. et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13, 134\u2013141 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnpjamd201513_CR50","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","volume":"277","author":"M Matsuda","year":"2002","unstructured":"Matsuda, M. et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 277, 37487\u201337491 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR51","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","volume":"100","author":"N Ouchi","year":"1999","unstructured":"Ouchi, N. et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473\u20132476 (1999).","journal-title":"Circulation"},{"key":"BFnpjamd201513_CR52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","volume":"23","author":"M Kumada","year":"2003","unstructured":"Kumada, M. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 23, 85\u201389 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnpjamd201513_CR53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1536\/ihj.48.149","volume":"48","author":"K Hara","year":"2007","unstructured":"Hara, K. et al. Reduced adiponectin level is associated with severity of coronary artery disease. Int. Heart J. 48, 149\u2013153 (2007).","journal-title":"Int. Heart J."},{"key":"BFnpjamd201513_CR54","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1295","volume":"11","author":"R Shibata","year":"2005","unstructured":"Shibata, R. et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096\u20131103 (2005).","journal-title":"Nat. Med."},{"key":"BFnpjamd201513_CR55","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/jnci\/dji376","volume":"97","author":"EK Wei","year":"2005","unstructured":"Wei, E. K., Giovannucci, E., Fuchs, C. S., Willett, W. C. & Mantzoros, C. S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Natl Cancer Inst. 97, 1688\u20131694 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnpjamd201513_CR56","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1078-0432.466.11.2","volume":"11","author":"M Ishikawa","year":"2005","unstructured":"Ishikawa, M. et al. Plasma adiponectin and gastric cancer. Clin. Cancer Res. 11, 466\u2013472 (2005).","journal-title":"Clin. Cancer Res."},{"key":"BFnpjamd201513_CR57","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/jc.2002-021209","volume":"88","author":"E Petridou","year":"2003","unstructured":"Petridou, E. et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J. Clin. Endocrinol. Metab. 88, 993\u2013997 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnpjamd201513_CR58","first-page":"5699","volume":"9","author":"Y Miyoshi","year":"2003","unstructured":"Miyoshi, Y. et al. Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9, 5699\u20135704 (2003).","journal-title":"Clin. Cancer Res."},{"key":"BFnpjamd201513_CR59","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1349-7006.2007.00486.x","volume":"98","author":"M Ishikawa","year":"2007","unstructured":"Ishikawa, M. et al. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci. 98, 1120\u20131127 (2007).","journal-title":"Cancer Sci."},{"key":"BFnpjamd201513_CR60","first-page":"339","volume":"34","author":"M Sugiyama","year":"2009","unstructured":"Sugiyama, M. et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK\/mTOR pathway. Int. J. Oncol. 34, 339\u2013344 (2009).","journal-title":"Int. J. Oncol."},{"key":"BFnpjamd201513_CR61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi, T. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762\u2013769 (2003).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR62","doi-asserted-by":"crossref","first-page":"19609","DOI":"10.1074\/jbc.M202045200","volume":"277","author":"IV Karpichev","year":"2002","unstructured":"Karpichev, I. V., Cornivelli, L. & Small, G. M. Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism. J. Biol. Chem. 277, 19609\u201319617 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","volume":"13","author":"T Yamauchi","year":"2007","unstructured":"Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332\u2013339 (2007).","journal-title":"Nat. Med."},{"key":"BFnpjamd201513_CR64","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M402367200","volume":"279","author":"A Tsuchida","year":"2004","unstructured":"Tsuchida, A. et al. Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279, 30817\u201330822 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnpjamd201513_CR65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2012.02.050","volume":"513","author":"K Kaarniranta","year":"2012","unstructured":"Kaarniranta, K. et al. Adiponectin receptor 1 gene (ADIPOR1) variant is associated with advanced age-related macular degeneration in Finnish population. Neurosci. Lett. 513, 233\u2013237 (2012).","journal-title":"Neurosci. Lett."},{"key":"BFnpjamd201513_CR66","doi-asserted-by":"crossref","first-page":"e111537","DOI":"10.1371\/journal.pone.0111537","volume":"9","author":"M Ishida","year":"2014","unstructured":"Ishida, M. et al. MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism. PLoS One 9, e111537 (2014).","journal-title":"PLoS One"},{"key":"BFnpjamd201513_CR67","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00125-004-1359-x","volume":"47","author":"AE Civitarese","year":"2004","unstructured":"Civitarese, A. E. et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 47, 816\u2013820 (2004).","journal-title":"Diabetologia"},{"key":"BFnpjamd201513_CR68","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature med 8, 1288\u20131295 (2002).","journal-title":"Nature med"},{"key":"BFnpjamd201513_CR69","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","volume":"464","author":"M Iwabu","year":"2010","unstructured":"Iwabu, M. et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1. Nature 464, 1313\u20131319 (2010).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","volume":"1","author":"BB Kahn","year":"2005","unstructured":"Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15\u201325 (2005).","journal-title":"Cell Metab."},{"key":"BFnpjamd201513_CR71","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167\u20131174 (2001).","journal-title":"J Clin Invest"},{"key":"BFnpjamd201513_CR72","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339\u2013343 (2002).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","volume":"2","author":"SA Hawley","year":"2005","unstructured":"Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9\u201319 (2005).","journal-title":"Cell Metab."},{"key":"BFnpjamd201513_CR74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2005.06.005","volume":"2","author":"A Woods","year":"2005","unstructured":"Woods, A. et al. Ca2+\/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21\u201333 (2005).","journal-title":"Cell Metab."},{"key":"BFnpjamd201513_CR75","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829\u2013839 (1998).","journal-title":"Cell"},{"key":"BFnpjamd201513_CR76","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature07206","volume":"454","author":"C Handschin","year":"2008","unstructured":"Handschin, C. & Spiegelman, B. M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454, 463\u2013469 (2008).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR77","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","volume":"403","author":"S Imai","year":"2000","unstructured":"Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795\u2013800 (2000).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR78","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai, S. & Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24, 464\u2013471 (2014).","journal-title":"Trends Cell Biol."},{"key":"BFnpjamd201513_CR79","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","volume":"26","author":"Z Gerhart-Hines","year":"2007","unstructured":"Gerhart-Hines, Z. et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha. EMBO J. 26, 1913\u20131923 (2007).","journal-title":"EMBO J."},{"key":"BFnpjamd201513_CR80","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056\u20131060 (2009).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR81","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1173635","volume":"325","author":"RJ Colman","year":"2009","unstructured":"Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201\u2013204 (2009).","journal-title":"Science"},{"key":"BFnpjamd201513_CR82","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"BFnpjamd201513_CR83","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1101\/gad.1255404","volume":"18","author":"J Apfeld","year":"2004","unstructured":"Apfeld, J., O'Connor, G., McDonagh, T., DiStefano, P. S. & Curtis, R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 18, 3004\u20133009 (2004).","journal-title":"Genes Dev."},{"key":"BFnpjamd201513_CR84","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature09706","volume":"470","author":"W Mair","year":"2011","unstructured":"Mair, W. et al. Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 470, 404\u2013408 (2011).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR85","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1106653","volume":"308","author":"SE Schriner","year":"2005","unstructured":"Schriner, S. E. et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909\u20131911 (2005).","journal-title":"Science"},{"key":"BFnpjamd201513_CR86","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.8108730","volume":"263","author":"WC Orr","year":"1994","unstructured":"Orr, W. C. & Sohal, R. S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263, 1128\u20131130 (1994).","journal-title":"Science"},{"key":"BFnpjamd201513_CR87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/534","volume":"19","author":"TL Parkes","year":"1998","unstructured":"Parkes, T. L. et al. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nature Genet. 19, 171\u2013174 (1998).","journal-title":"Nature Genet."},{"key":"BFnpjamd201513_CR88","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493\u2013499 (2013).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR89","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nature06325","volume":"450","author":"SG Rasmussen","year":"2007","unstructured":"Rasmussen, S. G. et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450, 383\u2013387 (2007).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature10236","volume":"475","author":"T Shimamura","year":"2011","unstructured":"Shimamura, T. et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 475, 65\u201370 (2011).","journal-title":"Nature"},{"key":"BFnpjamd201513_CR91","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature14301","volume":"520","author":"H Tanabe","year":"2015","unstructured":"Tanabe, H. et al. Crystal structures of the human adiponectin receptors. Nature 520, 312\u2013316 (2015).","journal-title":"Nature"}],"container-title":["npj Aging and Mechanisms of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjamd201513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjamd201513","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjamd201513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:48:28Z","timestamp":1672922908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjamd201513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,3]]}},"alternative-id":["BFnpjamd201513"],"URL":"https:\/\/doi.org\/10.1038\/npjamd.2015.13","relation":{},"ISSN":["2056-3973"],"issn-type":[{"value":"2056-3973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]},"assertion":[{"value":"6 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TK is a part of the Advisory Panel in Takeda, Daiichi-Sankyo, Tanabe-Mitsubishi, Taisho, Boehringer Ingelheim, Novo, is also a Consultant in MSD, Boehringer Ingelheim. TK is also a part of Research Support in Chugai, MSD, Ono, Daiichi-Sankyo, Tanabe-Mitsubishi, Sanofi, Astra Zeneca, Takeda, Boehringer Ingelheim, Novo, Novartis and is also a part of Speaker's Bureau in Boehringer Ingelheim, Daiichi-Sankyo, Tanabe-Mitsubishi, Astellas, Takeda, Ono, Kowa, Astra Zeneca, Dainippon- Sumitomo, Sanwa, Taisho, Eli Lilly, Kowa, Kyowahakko Kirin, MSD, Novartis, Sanofi. TY provides Research Support in Novo, Astellas, Ono, Daiichi-Sankyo, Tanabe-Mitsubishi, Takeda and is a part of Speaker's Bureau in Boehringer Ingelheim, Daiichi-Sankyo, Tanabe-Mitsubishi, Astellas, Takeda, Ono, Kowa, Astra Zeneca, Taisho, Eli Lilly, Kyowahakko Kirin, MSD, Novo. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15013"}}